β³ Fetching live dividend data...
Home βΊ Calculator βΊ NCNA Dividend Calculator 2026
NuCana plc Β· NASDAQ
Price: $1.36 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in NCNA β $84.72M in 10 years Β· $4,202,552.64/month
NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering advanced therapies for oncology. Its innovative product pipeline is underpinned by a proprietary ProTide technology platform. Among its key drug candidates, Acelarin is progressing through multiple clinical evaluations: a Phase I study for advanced solid tumors, Phase Ib trials for both recurrent ovarian cancer and biliary tract cancer, a Phase II trial targeting platinum-resistant ovarian cancer, and a pivotal Phase III trial for pancreatic cancer. NuCana is also developing NUC-3373, a ProTide derivative of 5-fluorouracilβs active anti-cancer metabolite. This compound is currently in a Phase I study for advanced solid tumors and a Phase Ib/2 trial for advanced colorectal cancer. Additionally, NUC-7738, a nucleoside analog, is undergoing Phase 1/2 clinical assessment for both advanced solid and hematological malignancies. To support its ProTide technology development, the company maintains research, collaboration, and licensing agreements with Cardiff University and University College Cardiff Consultants Ltd., covering the design, synthesis, characterization, and assessment of these compounds. Further collaborative and licensing arrangements are in place with Cardiff ProTides Ltd. Established in 1997, the company operated as NuCana BioMed Limited before rebranding to NuCana plc in August 2017. Its corporate headquarters are located in Edinburgh, United Kingdom.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open NCNA position with:
Real after-tax yield depends on where you live and how you hold NCNA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 147.06% | 144.26% | $14,706 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 125.00% | 122.20% | $12,500 / yr |
| πΊπΈ US Taxable (20%) | 20% | 117.65% | 114.85% | $11,765 / yr |
| π¬π§ UK ISA | 0% | 147.06% | 144.26% | $14,706 / yr |
| π¬π§ UK Taxable | 8.75% | 134.19% | 131.39% | $13,419 / yr |
| π¨π¦ TFSA | 0% | 147.06% | 144.26% | $14,706 / yr |
| π¨π¦ CA Taxable | 25% | 110.30% | 107.50% | $11,030 / yr |
| π¦πΊ Super (pension) | 15% | 125.00% | 122.20% | $12,500 / yr |
| π¦πΊ AU Taxable | 30% | 102.94% | 100.14% | $10,294 / yr |
| π©πͺ DE Taxable | 26.375% | 108.27% | 105.47% | $10,827 / yr |
| π«π· FR Taxable | 30% | 102.94% | 100.14% | $10,294 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
NCNA pays quarterly β 4 times per year. Next ex-div: TBD.
How NCNA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NCNA sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| D-Return | 2026-06-19 | 23,811,896 | β | β | ||
| D-Return | 2026-06-19 | 36,539,720 | β | β | ||
| A-Award | 2026-04-15 | 132,600,130 | β | β | ||
| Other | 2026-03-18 | 3 | β | β | ||
| Other | 2026-03-18 | 28,631,517 | β | β | ||
| Other | 2026-03-18 | 77,520,679 | β | β | ||
| Other | 2026-03-18 | 7 | β | β | ||
| Other | 2026-03-18 | 42,362,799 | β | β | ||
| Other | 2026-03-18 | 175,742,012 | β | β | ||
| Other | 2026-03-18 | 54,352,798 | β | β |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NCNA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
NuCana plc (NCNA) is currently trading at $1.36, trading near its 52-week low. The current dividend yield is 147.06% based on an annual payout of $2.00 per share.
NuCana plc (NCNA) is a healthcare stock currently trading at $1.36 with a dividend yield of 147.06%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β